An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood
Wissenschaftlicher Artikel
Authors
Danielsson, Angelika
Elgue, G.
Nilsson, Britt-Marie
Nilsson, Bo
Lambris, John D.
Institutions
UKU. Abteilung für GentherapiePublished in
Gene Therapy ; 17 (2010), 6. - S. 752-762. - ISSN 0969-7128. - eISSN 1476-5462
Link to publication
https://dx.doi.org/10.1038/gt.2010.18Keywords
human blood model; PEGylated adenovirus; immune response; cytokines; complement system; cell adhesion; POLYETHYLENE-GLYCOL MODIFICATION; INNATE IMMUNE-RESPONSES; PHASE-I TRIAL; ONCOLYTIC ADENOVIRUS; NEUTRALIZING ANTIBODIES; HUMAN-COMPLEMENT; GENE-TRANSFER; PROSTATE-CANCER; CLINICAL-TRIALS; VECTORSDewey Decimal Group
DDC 570 / Life sciencesDDC 610 / Medicine & health